Can high SHBG, low DHEA-S, thyroid dysfunction, and zinc insufficiency reduce androgen bioavailability and signaling?

Maintaining optimal androgen activity requires a delicate balance of transport proteins, precursor hormones, thyroid regulation, and crucial micronutrients. In aging men, disruptions in these pathways can collectively compromise physiological androgen action.

Circulating bioavailability and precursor pools

• Elevated SHBG: Sex hormone-binding globulin (SHBG) binds circulating testosterone with high affinity (Kd of ~0.8–1.4 nM), which is 10,000 to 100,000 times stronger than albumin. This tight sequestration reduces the biologically active free (~1–3%) and albumin-bound (~50–68%) fractions, lowering tissue bioavailability.
• Low DHEA-S: Dehydroepiandrosterone sulfate (DHEA-S) serves as the primary systemic reservoir for local, intracellular androgen synthesis. Depleted DHEA-S levels directly limit the substrate pool available for peripheral conversion into active testosterone and dihydrotestosterone (DHT).

Endocrine and receptor signaling mechanisms

• Thyroid dysfunction: Active thyroid hormone (T3) regulates hepatic SHBG synthesis via the HNF-4α pathway. Hypothyroidism reduces SHBG and compromises testicular Leydig cell maturation, LH receptor expression, and steroidogenesis. Conversely, hyperthyroidism elevates SHBG, which sequesters free testosterone.
• Zinc insufficiency: Zinc is a vital cofactor for Leydig cell steroidogenesis. Its deficiency impairs upstream testosterone production via Star and 3β-HSD. Downstream, the androgen receptor's DNA-binding domain structurally depends on two coordinated zinc-finger motifs; without zinc, the receptor cannot stably bind to genomic response elements, arresting transcription.

Bottom line

• High SHBG, low DHEA-S, thyroid imbalances, and zinc deficiency collectively suppress male androgenic activity by sequestering circulating hormones, depleting local synthesis substrates, and directly destabilizing androgen receptor-DNA binding.